NovaBay Pharmaceuticals, Inc.
NBY
$0.58
-$0.02-3.33%
| Weiss Ratings | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.61 | |||
| Price History | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.93% | |||
| 30-Day Total Return | -19.18% | |||
| 60-Day Total Return | -2.06% | |||
| 90-Day Total Return | 5.26% | |||
| Year to Date Total Return | -7.20% | |||
| 1-Year Total Return | -88.22% | |||
| 2-Year Total Return | -99.17% | |||
| 3-Year Total Return | -99.83% | |||
| 5-Year Total Return | -99.89% | |||
| 52-Week High % Change | -93.39% | |||
| 52-Week Low % Change | 66.16% | |||
| Price | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.08 | |||
| 52-Week Low Price | $0.36 | |||
| 52-Week Low Price (Date) | Aug 09, 2024 | |||
| 52-Week High Price (Date) | May 17, 2024 | |||
| Valuation | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.93M | |||
| Enterprise Value | 3.42M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -53.60 | |||
| Earnings Per Share Growth | -77.58% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.20 | |||
| Price/Book (Q) | 2.75 | |||
| Enterprise Value/Revenue (TTM) | 0.31 | |||
| Price | $0.58 | |||
| Enterprise Value/EBITDA (TTM) | -0.78 | |||
| Enterprise Value/EBIT | -0.76 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.71M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 510 899 8800 | |||
| Address | 2000 Powell Street EmeryVille, CA 94608 | |||
| Website | novabay.com | |||
| Country | United States | |||
| Year Founded | 2000 | |||
| Profitability | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -40.03% | |||
| Profit Margin | -90.35% | |||
| Management Effectiveness | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -33.50% | |||
| Return on Equity | -- | |||
| Income Statement | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 11.15M | |||
| Total Revenue (TTM) | 11.20M | |||
| Revenue Per Share | $3.02 | |||
| Gross Profit (TTM) | 6.79M | |||
| EBITDA (TTM) | -4.40M | |||
| EBIT (TTM) | -4.48M | |||
| Net Income (TTM) | -10.12M | |||
| Net Income Avl. to Common (TTM) | -10.12M | |||
| Total Revenue Growth (Q YOY) | -1.61% | |||
| Earnings Growth (Q YOY) | 10.42% | |||
| EPS Diluted (TTM) | -53.60 | |||
| EPS Diluted Growth (Q YOY) | 95.44% | |||
| Balance Sheet | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 776.00K | |||
| Cash Per Share (Q) | $0.21 | |||
| Total Current Assets (Q) | 2.28M | |||
| Total Preferred Equity (Q) | 0.01 | |||
| Total Equity (Q) | 1.07M | |||
| Current Ratio (Q) | 1.149 | |||
| Book Value Per Share (Q) | $0.22 | |||
| Total Assets (Q) | 3.88M | |||
| Total Current Liabilities (Q) | 1.98M | |||
| Total Debt (Q) | 1.26M | |||
| Total Liabilities (Q) | 2.81M | |||
| Total Common Equity (Q) | 1.07M | |||
| Cash Flow | NBY - AMEX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.06M | |||
| Cash from Financing (TTM) | 974.00K | |||
| Net Change in Cash (TTM) | -2.70M | |||
| Levered Free Cash Flow (TTM) | 616.80K | |||
| Cash from Operations (TTM) | -4.73M | |||
